롱 리드 시퀀싱 시장 규모, 점유율, 성장 분석 : 제공별, 기술별, 워크플로우별, 용도별, 사용 방법별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Long Read Sequencing Market size was valued at USD 779.92 Million in 2024 and is poised to grow from USD 1020.92 Million in 2025 to USD 8800.49 Million by 2033, growing at a CAGR of 30.9% during the forecast period (2026-2033).

The global market for long read sequencing (LRS) is being driven by the rising incidence of genetic disorders, the increasing appeal of personalized medicine, and significant technological advancements like third-generation sequencing. The demand for innovative sequencing techniques has surged due to their utility in diagnostics and drug development, particularly influenced by the global health crisis. LRS, including methods like Single Molecule Real Time (SMRT) and Nanopore sequencing, offers distinct advantages such as accurate genome assembly and the detection of complex genomic features that traditional sequencing struggles to identify. Enhanced capability to analyze challenging genetic regions and chromosomal abnormalities positions LRS as a pivotal tool in clinical research, while major investments in advanced genomic technologies from industry leaders promise to further accelerate market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Long Read Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Long Read Sequencing Market Segments Analysis

Global Long Read Sequencing Market is segmented by Offerings, Technology, Workflow, Application, Usage, End Users and region. Based on Offerings, the market is segmented into Consumables, Instruments and Services. Based on Technology, the market is segmented into Nanopore sequencing, Single-molecule real-time sequencing and Synthetic long-read sequencing. Based on Workflow, the market is segmented into Sequencing, Sample Preparation and Data analysis. Based on Application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, Metagenomics, Epigenetics, Whole exome sequencing and Other applications. Based on Usage, the market is segmented into Research and Clinical. Based on End Users, the market is segmented into Academic & Research Institutes, Hospitals, Clinics & Diagnostic Labs, Pharmaceutical & Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Long Read Sequencing Market

The global market for Long Read Sequencing is significantly propelled by the widespread utilization of next-generation sequencing (NGS) technologies in diverse research domains such as genomics, transcriptomics, and epigenomics. The ability of long read sequencing to enhance our understanding of genome assembly, gene expression, and DNA modification patterns contributes greatly to its growing acceptance and integration into NGS-focused research initiatives. Researchers increasingly rely on this technology for its ability to provide deeper insights and more comprehensive data, thereby fostering innovation and advancements in various scientific disciplines and promoting its extensive adoption within the global research community.

Restraints in the Global Long Read Sequencing Market

The global long read sequencing market faces challenges due to the comparatively higher expenses associated with these technologies when measured against traditional short read sequencing methods. The financial burden stems from the costs of specialized instruments, reagents, and comprehensive data analysis, which can be substantial. This economic factor can hinder the widespread adoption of long read sequencing in various environments, particularly in clinical diagnostics and research facilities that may have limited resources. As a result, cost considerations may restrict the integration of these advanced sequencing solutions into more routine applications and settings.

Market Trends of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is experiencing robust growth as researchers and healthcare professionals increasingly recognize the superiority of long read technologies for delivering detailed and precise genomic insights. This shift is fueled by a burgeoning demand across diverse applications, including genome assembly, structural variant analysis, and transcriptomics. As the limitations of traditional short read sequencing become more apparent, the industry is witnessing a heightened emphasis on innovative solutions that can navigate complex genetic landscapes. The ongoing advancements in long read sequencing technologies are poised to further catalyze their adoption, enhancing research capabilities and driving personalized medicine forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Long Read Sequencing Market Size by Offerings & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments
• Services

Global Long Read Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Nanopore sequencing
• Single-molecule real-time sequencing
• Synthetic long-read sequencing

Global Long Read Sequencing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sequencing
• Sample Preparation
• Data analysis

Global Long Read Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Whole Genome Sequencing
• Targeted Sequencing
• Metagenomics
• Epigenetics
• Whole exome sequencing
• Other applications

Global Long Read Sequencing Market Size by Usage & CAGR (2026-2033)

• Market Overview
• Research
• Clinical

Global Long Read Sequencing Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Hospitals, Clinics & Diagnostic Labs
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Long Read Sequencing Market Size & CAGR (2026-2033)

• North America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • US
  • Canada
• Europe (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offerings, Technology, Workflow, Application, Usage, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offerings, Technology, Workflow, Application, Usage, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pacific Biosciences of California, Inc. (PacBio) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations